Hikma Pharmaceuticals PLC Strategy, SWOT and Corporate Finance Report Prices from USD $175

12:01 EST 11 Jan 2017 | BioPortfolio Reports

Hikma Pharmaceuticals PLC Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.

Key Findings
Detailed information on Hikma Pharmaceuticals PLC required for business and competitor intelligence needs
A study of the major internal and external factors affecting Hikma Pharmaceuticals PLC in the form of a SWOT analysis
An indepth view of the business model of Hikma Pharmaceuticals PLC including a breakdown and examination of key business segments
Intelligence on Hikma Pharmaceuticals PLC's mergers and acquisitions MandA, strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
News about Hikma Pharmaceuticals PLC, such as business expansion, restructuring, and contract wins
Large number of easytograsp charts and graphs that present important data and key trends

Gain understanding of Hikma Pharmaceuticals PLC and the factors that influence its strategies
Track strategic initiatives of the company and latest corporate news and actions
Assess Hikma Pharmaceuticals PLC as a prospective partner, vendor or supplier
Support sales activities by understanding your customers' businesses better
Stay up to date on Hikma Pharmaceuticals PLC's business structure, strategy and prospects

Key Highlights
Hikma Pharmaceuticals Hikma or 'the company' is engaged in the development, manufacture and marketing of generic and inlicensed pharmaceutical products. The company primarily operates in the Middle East and North Africa MENA, the US and Europe. It is headquartered in London, the UK and employs around 7,248 people.

Original Article: Hikma Pharmaceuticals PLC Strategy, SWOT and Corporate Finance Report Prices from USD $175


More From BioPortfolio on "Hikma Pharmaceuticals PLC Strategy, SWOT and Corporate Finance Report Prices from USD $175"

Quick Search

Relevant Topics

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...